Search Results - "Edith Swann"

Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand by Robb, Merlin L, Eller, Leigh A, Kibuuka, Hannah, Rono, Kathleen, Maganga, Lucas, Nitayaphan, Sorachai, Kroon, Eugene, Sawe, Fred K, Sinei, Samuel, Sriplienchan, Somchai, Jagodzinski, Linda L, Malia, Jennifer, Manak, Mark, de Souza, Mark S, Tovanabutra, Sodsai, Sanders-Buell, Eric, Rolland, Morgane, Dorsey-Spitz, Julie, Eller, Michael A, Milazzo, Mark, Li, Qun, Lewandowski, Andrew, Wu, Hao, Swann, Edith, O'Connell, Robert J, Peel, Sheila, Dawson, Peter, Kim, Jerome H, Michael, Nelson L

“…Acute human immunodeficiency virus type 1 (HIV-1) infection is a major contributor to transmission of HIV-1. An understanding of acute HIV-1 infection may be…”
Get full text

Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk by Neidich, Scott D, Fong, Youyi, Li, Shuying S, Geraghty, Daniel E, Williamson, Brian D, Young, William Chad, Goodman, Derrick, Seaton, Kelly E, Shen, Xiaoying, Sawant, Sheetal, Zhang, Lu, deCamp, Allan C, Blette, Bryan S, Shao, Mengshu, Yates, Nicole L, Feely, Frederick, Pyo, Chul-Woo, Ferrari, Guido, Frank, Ian, Karuna, Shelly T, Swann, Edith M, Mascola, John R, Graham, Barney S, Hammer, Scott M, Sobieszczyk, Magdalena E, Corey, Lawrence, Janes, Holly E, McElrath, M Juliana, Gottardo, Raphael, Gilbert, Peter B, Tomaras, Georgia D

“…HVTN 505 is a preventative vaccine efficacy trial testing DNA followed by recombinant adenovirus serotype 5 (rAd5) in circumcised, Ad5-seronegative men and…”
Get full text

Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa by Gray, Glenda E, Huang, Ying, Grunenberg, Nicole, Laher, Fatima, Roux, Surita, Andersen-Nissen, Erica, De Rosa, Stephen C, Flach, Britta, Randhawa, April K, Jensen, Ryan, Swann, Edith M, Bekker, Linda-Gail, Innes, Craig, Lazarus, Erica, Morris, Lynn, Mkhize, Nonhlanhla N, Ferrari, Guido, Montefiori, David C, Shen, Xiaoying, Sawant, Sheetal, Yates, Nicole, Hural, John, Isaacs, Abby, Phogat, Sanjay, DiazGranados, Carlos A, Lee, Carter, Sinangil, Faruk, Michael, Nelson L, Robb, Merlin L, Kublin, James G, Gilbert, Peter B, McElrath, M Juliana, Tomaras, Georgia D, Corey, Lawrence

“…One of the most successful HIV vaccines to date, the RV144 vaccine tested in Thailand, demonstrated correlates of protection including cross-clade V1V2…”
Get more information

Does per‐act HIV‐1 transmission risk through anal sex vary by gender? An updated systematic review and meta‐analysis by Baggaley, Rebecca F., Owen, Branwen N., Silhol, Romain, Elmes, Jocelyn, Anton, Peter, McGowan, Ian, Straten, Ariane, Shacklett, Barbara, Dang, Que, Swann, Edith M., Bolton, Diane L., Boily, Marie‐Claude

“…Quantifying HIV‐1 transmission risk per‐act of anal intercourse (AI) is important for HIV‐1 prevention. We updated previous reviews by searching Medline and…”
Get full text

Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01 by Huang, Yunda, Zhang, Lily, Karuna, Shelly, Andrew, Philip, Juraska, Michal, Weiner, Joshua A., Angier, Heather, Morgan, Evgenii, Azzam, Yasmin, Swann, Edith, Edupuganti, Srilatha, Mgodi, Nyaradzo M., Ackerman, Margaret E., Donnell, Deborah, Gama, Lucio, Anderson, Peter L., Koup, Richard A., Hural, John, Cohen, Myron S., Corey, Lawrence, McElrath, M. Juliana, Gilbert, Peter B., Lemos, Maria P.

“…Broadly neutralizing monoclonal antibodies (mAbs) are being developed for HIV-1 prevention. Hence, these mAbs and licensed oral pre-exposure prophylaxis (PrEP)…”
Get full text

Induction of HIV-1–Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans by Baden, Lindsey R., Liu, Jinyan, Li, Hualin, Johnson, Jennifer A., Walsh, Stephen R., Kleinjan, Jane A., Engelson, Brian A., Peter, Lauren, Abbink, Peter, Milner, Danny A., Golden, Kevin L., Viani, Kyle L., Stachler, Matthew D., Chen, Benjamin J., Pau, Maria G., Weijtens, Mo, Carey, Brittany R., Miller, Caroline A., Swann, Edith M., Wolff, Mark, Loblein, Hayley, Seaman, Michael S., Dolin, Raphael, Barouch, Dan H.

“…Background. Defining mucosal immune responses and inflammation to candidate human immunodeficiency virus type 1 (HIV-1) vaccines represents a current research…”
Get full text

HIV incidence and its associated factors among young adults with multiple sexual partners in Maputo, Mozambique: a vaccine preparedness study by Macicame, Ivalda, Bhatt, Nilesh, Viegas, Edna, Yates, Adam, Nwoga, Chiaka, Chissumba, Raquel Matavele, Monteiro, Vanessa, Imbach, Michelle, Milazzo, Mark, Li, Qun, Schech, Steven, Mebrahtu, Tsedal, Eller, Leigh Anne, Swann, Edith, Michael, Nelson L, Robb, Merlin L, Crowell, Trevor A, Polyak, Christina S, Jani, Ilesh

“…Sub-Saharan Africa has a high burden of HIV, particularly among female sex workers (FSW) and men who have sex with men (MSM). Future clinical trials to…”
Get full text

Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection by Lama, Javier R, Karuna, Shelly T, Grant, Shannon P, Swann, Edith M, Ganoza, Carmela, Segura, Patricia, Montano, Silvia M, Lacherre, Martin, De Rosa, Stephen C, Buchbinder, Susan, Sanchez, Jorge, McElrath, M Juliana, Lemos, Maria P

“…Rectal and genital sampling in HIV prevention trials permits assessments at the site of HIV entry. Yet the safety and acceptability of circumcision and…”
Get full text

Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083 by Walsh, Stephen R., Moodie, Zoe, Fiore-Gartland, Andrew J., Morgan, Cecilia, Wilck, Marissa B., Hammer, Scott M., Buchbinder, Susan P., Kalams, Spyros A., Goepfert, Paul A., Mulligan, Mark J., Keefer, Michael C., Baden, Lindsey R., Swann, Edith M., Grant, Shannon, Ahmed, Hasan, Li, Fusheng, Hertz, Tomer, Self, Steven G., Friedrich, David, Frahm, Nicole, Liao, Hua-Xin, Montefiori, David C., Tomaras, Georgia D., McElrath, M. Juliana, Hural, John, Graham, Barney S., Jin, Xia

“…Background. Increasing the breadth of human immunodeficiency virus type 1 (HIV-1) vaccine-elicited immune responses or targeting conserved regions may improve…”
Get full text

Helios expressing regulatory T cells are correlated with decreased IL-2 producing CD8 T cells and antibody diversity in Mozambican individuals living chronically with HIV-1 by Matavele Chissumba, Raquel, Magul, Cacildo, Macamo, Rosa, Monteiro, Vânia, Enosse, Maria, Macicame, Ivalda, Cumbane, Victória, Bhatt, Nilesh, Viegas, Edna, Imbach, Michelle, Eller, Leigh Anne, Polyak, Christina S, Kestens, Luc

“…Human immunodeficiency virus type 1 (HIV-1) causes impairment of T and B cell responses, which begins during the acute phase of infection and is not completely…”
Get full text

First-in-Human Evaluation of a Hexon Chimeric Adenovirus Vector Expressing HIV-1 Env (IPCAVD 002) by Baden, Lindsey R., Walsh, Stephen R., Seaman, Michael S., Johnson, Jennifer A., Tucker, Robert P., Kleinjan, Jane A., Gothing, Jon A., Engelson, Brian A., Carey, Brittany R., Oza, Avinash, Bajimaya, Shringkhala, Peter, Lauren, Bleckwehl, Chelsea, Abbink, Peter, Pau, Maria G., Weijtens, Mo, Kunchai, Meghan, Swann, Edith M., Wolff, Mark, Dolin, Raphael, Barouch, Dan H.

“…Background. We report the first-in-human safety and immunogenicity assessment of a prototype hexon chimeric adenovirus (Ad) serotype 5 (Ad5) vector containing…”
Get full text

How common and frequent is heterosexual anal intercourse among South Africans? A systematic review and meta‐analysis by Owen, Branwen N., Elmes, Jocelyn, Silhol, Romain, Dang, Que, McGowan, Ian, Shacklett, Barbara, Swann, Edith M., Straten, Ariane, Baggaley, Rebecca F., Boily, Marie‐Claude

“…Background: HIV is transmitted more effectively during anal intercourse (AI) than vaginal intercourse (VI). However, patterns of heterosexual AI practice and…”
Get full text

Conceptual framework for behavioral and social science in HIV vaccine clinical research by Lau, Chuen-Yen, Swann, Edith M, Singh, Sagri, Kafaar, Zuhayr, Meissner, Helen I, Stansbury, James P

“…Abstract HIV vaccine clinical research occurs within a context where biomedical science and social issues are interlinked. Previous HIV vaccine research has…”
Get full text

Behavioral and social science in HIV vaccine clinical research: Workshop report by Lau, Chuen-Yen, Swann, Edith M, Singh, Sagri

“…Abstract In May 2009, a workshop was held in Washington DC to identify ways in which HIV vaccine clinical research could benefit from and better incorporate…”
Get full text

Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP ® DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults by Edupuganti, Srilatha, C De Rosa, Stephen, Elizaga, Marnie, Lu, Yiwen, Han, Xue, Huang, Yunda, Swann, Edith, Polakowski, Laura, A Kalams, Spyros, Keefer, Michael, Maenza, Janine, C Wise, Megan, Yan, Jian, Morrow, Matthew P, Khan, Amir S, Boyer, Jean D, Humeau, Laurent, White, Scott, Sardesai, Niranjan Y, Bagarazzi, Mark L, Gilbert, Peter B, Kublin, James G, Corey, Lawrence, Weiner, David B, On Behalf Of The Hvtn Study Team, The Niaid-Funded Hiv Vaccine Trials Network

“…Several techniques are under investigation to improve the immunogenicity of HIV-1 DNA vaccine candidates. DNA vaccines are advantageous due to their ease of…”
Get full text

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19) by Barouch, Dan H, Tomaka, Frank L, Wegmann, Frank, Stieh, Daniel J, Alter, Galit, Robb, Merlin L, Michael, Nelson L, Peter, Lauren, Nkolola, Joseph P, Borducchi, Erica N, Chandrashekar, Abishek, Jetton, David, Stephenson, Kathryn E, Li, Wenjun, Korber, Bette, Tomaras, Georgia D, Montefiori, David C, Gray, Glenda, Frahm, Nicole, McElrath, M Juliana, Baden, Lindsey, Johnson, Jennifer, Hutter, Julia, Swann, Edith, Karita, Etienne, Kibuuka, Hannah, Mpendo, Juliet, Garrett, Nigel, Mngadi, Kathy, Chinyenze, Kundai, Priddy, Frances, Lazarus, Erica, Laher, Fatima, Nitayapan, Sorachai, Pitisuttithum, Punnee, Bart, Stephan, Campbell, Thomas, Feldman, Robert, Lucksinger, Gregg, Borremans, Caroline, Callewaert, Katleen, Roten, Raphaele, Sadoff, Jerald, Scheppler, Lorenz, Weijtens, Mo, Feddes-de Boer, Karin, van Manen, Daniëlle, Vreugdenhil, Jessica, Zahn, Roland, Lavreys, Ludo, Nijs, Steven, Tolboom, Jeroen, Hendriks, Jenny, Euler, Zelda, Pau, Maria G, Schuitemaker, Hanneke

“…More than 1·8 million new cases of HIV-1 infection were diagnosed worldwide in 2016. No licensed prophylactic HIV-1 vaccine exists. A major limitation to date…”
Get full text

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S by Sadoff, Jerald, Gray, Glenda, Vandebosch, An, Cárdenas, Vicky, Shukarev, Georgi, Grinsztejn, Beatriz, Goepfert, Paul A, Truyers, Carla, Van Dromme, Ilse, Spiessens, Bart, Vingerhoets, Johan, Custers, Jerome, Scheper, Gert, Robb, Merlin L, Treanor, John, Ryser, Martin F, Barouch, Dan H, Swann, Edith, Marovich, Mary A, Neuzil, Kathleen M, Corey, Lawrence, Stoddard, Jeffrey, Hardt, Karin, Ruiz-Guiñazú, Javier, Le Gars, Mathieu, Schuitemaker, Hanneke, Van Hoof, Johan, Struyf, Frank, Douoguih, Macaya

“…The randomized trial assessing the efficacy of a single injection of the Ad26.COV2.S showed 56.3% vaccine efficacy beginning 14 days after injection and 52.9%…”
Get full text

Advancing long-acting and extended delivery HIV prevention and treatment regimens through behavioural science: NIH workshop directions by Morton, Tia, Chege, Wairimu, Swann, Edith, Senn, Theresa E., Cleland, Naana, Renzullo, Philip O., Stirratt, Michael J.

Get full text

Advancing long-acting and extended delivery HIV prevention and treatment regimens through behavioral science: NIH workshop directions by Morton, Tia, Chege, Wairimu, Swann, Edith, Senn, Theresa E., Cleland, Naana, Renzullo, Philip O., Stirratt, Michael J.

Get full text

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001) by Baden, Lindsey R., Walsh, Stephen R., Seaman, Michael S., Tucker, Robert P., Krause, Kathleen H., Patel, Alka, Johnson, Jennifer A., Kleinjan, Jane, Yanosick, Katherine E., Perry, James, Zablowsky, Elise, Abbink, Peter, Peter, Lauren, Iampietro, Mark Justin, Cheung, Ann, Pau, Maria G., Weijtens, Mo, Goudsmit, Jaap, Swann, Edith, Wolff, Mark, Loblein, Hayley, Dolin, Raphael, Barouch, Dan H.

“…Background. We report the first-in-human safety and immunogenicity assessment of a prototype Ad26 vector-based human immunodeficiency virus (HIV) vaccine in…”
Get full text